PA
KRNY icon

PharVision Advisers’s Kearny Financial KRNY Stock Holding History

PharVision Advisers’s Portfolio KRNY Stock Details KRNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,656
Closed -$123K – 858
2025
Q3 		$123K Buy
+18,656
New +$120K 0.07% 599
2025
Q1 		– Sell
-14,997
Closed -$106K – 403
2024
Q4 		$106K Buy
+14,997
New +$113K 0.09% 371

Other funds holding KRNY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

PharVision Advisers's KRNY Position: Q4 2025 in Review

PharVision Advisers sold out of Kearny Financial (KRNY) in Q4 2025, closing a stake of 18,656 shares — an estimated $123K sold.

PharVision Advisers first reported a position in KRNY in Q4 2024 and held it in 2 quarters. The position peaked at $123K in Q3 2025. 177 funds tracked by Wall St. Rank hold KRNY as of Q4 2025.

  • PharVision Advisers reported no remaining Kearny Financial position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 18,656 Kearny Financial shares in Q4 2025, an estimated $123K.
  • PharVision Advisers first reported a position in Kearny Financial in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's Kearny Financial position peaked at $123K in Q3 2025.
  • 177 funds tracked by Wall St. Rank held Kearny Financial as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.